ALTIMMUNE, INC. Tax Withholding Paid on Stock Awards
ALTIMMUNE, INC. (ALT) reported Tax Withholding Paid on Stock Awards of $695.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-05-13
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $695.00K, a 2.51% increase year-over-year.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $25.00K, a 1150.00% increase year-over-year.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-06-30 was $6.00K, a 97.54% decline year-over-year.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $709.00K, a 16.59% decline from fiscal 2024.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $850.00K, a 57.70% increase from fiscal 2023.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $539.00K, a 4.46% increase from fiscal 2022.
- ALTIMMUNE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $516.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-03-31 | $695.00K 10-Q · filed 2026-05-13 | $720.00K derived: sum of 2 quarters · filed 2026-05-13 | $720.00K derived: sum of 3 quarters · filed 2026-05-13 | $726.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $25.00K derived: sum of 2 quarters · filed 2026-03-06 | $31.00K derived: sum of 3 quarters · filed 2026-03-06 | $709.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.00K derived: sum of 2 quarters · filed 2025-11-06 | $684.00K 10-Q · filed 2025-11-06 | $686.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $684.00K 10-Q · filed 2025-08-12 | $686.00K derived: sum of 3 quarters · filed 2026-05-13 | $690.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-03-31 | $678.00K 10-Q · filed 2026-05-13 | $680.00K derived: sum of 2 quarters · filed 2026-05-13 | $684.00K derived: sum of 3 quarters · filed 2026-05-13 | $928.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $6.00K derived: sum of 2 quarters · filed 2026-03-06 | $250.00K derived: sum of 3 quarters · filed 2026-03-06 | $850.00K 10-K · filed 2026-03-06 |
| 2024-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $248.00K derived: sum of 2 quarters · filed 2025-11-06 | $848.00K 10-Q · filed 2025-11-06 | $885.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $844.00K 10-Q · filed 2025-08-12 | $881.00K derived: sum of 3 quarters · filed 2025-08-12 | $883.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $600.00K 10-Q · filed 2025-05-13 | $637.00K derived: sum of 2 quarters · filed 2025-05-13 | $639.00K derived: sum of 3 quarters · filed 2025-05-13 | $654.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $39.00K derived: sum of 2 quarters · filed 2025-02-27 | $54.00K derived: sum of 3 quarters · filed 2025-02-27 | $539.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $17.00K derived: sum of 2 quarters · filed 2024-11-12 | $502.00K 10-Q · filed 2024-11-12 | $627.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $500.00K 10-Q · filed 2024-08-08 | $625.00K derived: sum of 3 quarters · filed 2024-08-08 | $766.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $485.00K 10-Q · filed 2024-05-09 | $610.00K derived: sum of 2 quarters · filed 2024-05-09 | $751.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $266.00K derived: sum of 2 quarters · filed 2024-03-27 | $516.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $391.00K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $250.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |